The European private equity firm is buying a majority stake in Intelerad Medical Systems from Canadian private equity firm Novacap. The deal is expected to close in the first quarter. (The Logic)
The European private equity firm is buying a majority stake in Intelerad Medical Systems from Canadian private equity firm Novacap. The deal is expected to close in the first quarter. (The Logic)
The European private equity firm is buying a majority stake in Intelerad Medical Systems from Canadian private equity firm Novacap. The deal is expected to close in the first quarter. (The Logic)
Talking point: This is the first Canadian investment for Hg and the second made by its New York office, which opened last year. Although Hg is now the majority shareholder, Novacap, which initially invested in 2016, will still hold a stake in the firm as it seeks to expand both through organic growth and mergers and acquisitions. Intelerad’s top line has increased by over 20 per cent year-over-year since Novacap’s investment. The firm currently has over 400 employees serving over 300 health-care organizations around the world. Today’s investment values Intelerad at over $650 million.
Loading...
You have shared 5 articles this month and reached the maximum amount of shares available.
CloseIf you would like to purchase a sharing license please contact The Logic support at [email protected].
CloseYou have gifted 0 article(s) this month and have 5 remaining.
Recipients will be able to read the full text of the article after submitting their email address. They will not have access to other articles or subscriber benefits.
Get up to speed in minutes with insights and analysis on the most important stories of the day, every weekday.
See the bigger picture with reporters and industry experts in subscriber-exclusive events.
Membership provides access to our popular Slack channel, participation in subscriber surveys and invitations to exclusive events with our journalists and special guests.